X
Home
About us
Mission
Researchers
Our funders
Our research
Introduction
Improvement of Care and Outcome
Precision Prediction & Precision Medicine
Psychosocial Aspects
Ongoing Studies/Trials
Value-based healthcare
Library
Publications
Posters & Presentations
Videos
News
Home
About us
Mission
Researchers
Our funders
Our research
Introduction
Improvement of Care and Outcome
Precision Prediction & Precision Medicine
Psychosocial Aspects
Ongoing Studies/Trials
Value-based healthcare
Library
Publications
Posters & Presentations
Videos
News
LATEST NEWS
June 20, 2023
UPDATE PUBLICATIONS
We have updated the Diabeter Research website with a number of publications of studies in which Diabeter authors were involved:
April 12, 2023
UPDATE PSYCHOLOGY PUBLICATIONS 2022-2023
We have updated the Diabeter Research website with a number of publications of studies in which Diabeter psychologist Giesje Nefs was involved:
March 7, 2023
SECOND PUBLICATION OF JDRF-PROJECT ‘BIOMARKERS OF HETEROGENEITY IN TYPE 1 DIABETES’
C-peptide and long-standing T1D
July 4, 2022
UPDATE PUBLICATIONS FIRST HALF OF 2022
We have updated the Diabeter Research website with a number of publications of studies in which Diabeter, or employees of Diabeter, were involved
January 25, 2022
UPDATE PUBLICATIONS 2021/2022
We have updated the Diabeter Research website with a number of publications of studies in which Diabeter, or employees of Diabeter, were involved
November 17, 2021
CONSENSUS STATEMENT DO-IT-YOURSELF AUTOMATED INSULIN DELIVERY SYSTEMS
Recently a consensus statement on the use of open-source insulin delivery (AID) systems was published. Diabeter pediatrician Per Winterdijk, himself an open-source AID system user, contributed to the statement
November 10, 2021
LIFE EXPECTANCY, MORTALITY, PREVENTION OF COMPLICATIONS AND HOPE
Disturbing statistics on diabetes were presented in the Dutch press in October 2021
October 4, 2021
FIRST PUBLICATION OF JDRF-PROJECT ‘BIOMARKERS OF HETEROGENEITY IN TYPE 1 DIABETES’
C-peptide and impaired awareness of glycemia
June 1, 2021
PROGRESS TOWARDS PREVENTION OF TYPE 1 DIABETES: TEPLIZUMAB
Approval of Teplizumab for further application and development
February 15, 2021
“NEW CLOSED-LOOP INSULIN SYSTEMS”: REVIEW OF RECENT CLOSED-LOOP SYSTEMS
February 2, 2021
DIAMYD MEDICAL META-ANALYSIS UPDATED WITH RESULTS FROM DIAGNODE-2 TRIAL
September 17, 2020
DIAMYD MEDICAL PRESENTS RESULTS FROM DIAGNODE 2 TRIAL
September 7, 2020
DIAMYD®: ANOTHER STEP TOWARDS INDIVIDUALIZED THERAPY FOR TYPE 1 DIABETES
July 20, 2020
DIAGNODE-2: RESULTS FROM TRIAL WITH DIABETES VACCINE DIAMYD® (GAD65-ALUM) EXPECTED SEPTEMBER 2020
April 20, 2020
TYPE 1 DIABETES CARE IN COVID-19 TIMES: THE DIABETER EXPERIENCE
February 21, 2020
NEWS FROM ATTD 2020
February 4, 2020
PROF. EELCO DE KONING’S RESEARCH GROUP HAS BEEN GRANTED 1.2 MILLION EUROS FOR TWO HORIZON 2020-PROJECTS ON STEM CELL PRODUCTS
January 30, 2020
DIABETER INTERNSHIP ON THE ROLE OF PRECONCEPTION GLYCEMIC VARIABILITY IN PREGNANCY/DELIVERY IN WOMEN WITH T1D
December 18, 2019
PHASE I/II TRIAL REGENERATE-1 WITH GABA FORMULATION HAS STARTED
Recently published press release from Diamyd
December 17, 2019
A NEW WAY OF LOOKING AT HETEROGENEITY IN TYPE 1 DIABETES: THE ENDOTYPE
Recently published in Diabetes Care
December 3, 2019
SCREENING FOR TYPE 1 DIABETES?
Update from ISPAD 2019
© 2019 Diabeter |
Terms of Use
|
Privacy Statement